Abbott Settles Baby Formula Claims For $385 Million

Abbott will pay $385 million to settle state, federal, and civil lawsuits stemming from contamination issues at its Michigan baby formula plant in early 2022.

Abbott agrees to $385 million settlement in baby formula case

Some federal prosecutors believed there was enough evidence to bring criminal charges, but Justice Department leadership opted for a civil settlement.

Infant formula company agrees to pay nearly $1M to Conn. for allegedly providing noncompliant products to Medicaid program

HARTFORD, Conn. (WTNH) — Abbott Laboratories, otherwise known as Abbott, agreed to pay over $384 million to settle the False Claims Act allegations that it had failed to manufacture certain powder infant formula and nutritional therapy products in compliance with federal and state requirements.

FDA says infant formula 'safe.' Parents whose babies got botulism want answers

The U.S. Food and Drug Administration claimed its sweeping test results confirm America's infant formula supply is safe.Our investigation uncovered a glaring o

Abbott reaches agreement with Department of Justice to resolve claims relating to 2022 infant formula recall

Abbott (NYSE: ABT) has reached an agreement to resolve the previously disclosed investigation and lawsuit brought by the United States Department of Justice, as well as lawsuits filed by certain relators and the Attorneys General of several states,

Inspection finds expired infant formula at Springfield grocery store

A grocery store had multiple cans of expired infant formula on its shelves, according to a Sept. 3 health inspection report.
Quality Assurance & Food Safety

IDFA Supports New Report Charting Path Forward on Infant Formula Safety

The International Dairy Foods Association (IDFA) welcomed the release of a new report from the Reagan-Udall Foundation for the FDA outlining a science-based roadmap for industry, government and academic partners to address Clostridium botulinum risk in powdered infant formula.